Late last year, Health Canada approved lecanemab, a monoclonal antibody that clears amyloid plaques — a hallmark indicator of Alzheimer’s disease — in people with early-stage dementia while symptoms ...

Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease. Using advanced computer modeling, researchers discovered that ...

A new Alzheimer's treatment side effect that results in brain swelling may have an upside, according to a new study from ...

Dr. Yoshiteru Shimoide, immunologist and director of the Yoshiteru Shimoide Internal Medicine Clinic in Kagoshima, Japan, has developed RO‑8, the world’s first therapeutic agent designed to ...

Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s ...

The researchers deployed a newly developed machine learning system called SIGNET – Statistical Inference on Gene Regulatory ...

Researchers from the NeuroAD group (Neuropathology of Alzheimer's Disease) within the Department of Cell Biology, Genetics ...

A new study study finds that brain swelling (ARIA-E) from Alzheimer's drugs identifies the regions where amyloid plaques are being cleared most effectively.

Globally, millions of people are affected by Alzheimer's disease, with around 120,000 individuals in Norway alone. Witnessing ...

Discussion will focus on the high unmet need and the lack of FDA-approved treatment options associated with acute agitation episodes in Alzheimer’s dementia ...

By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...

Findings could streamline enrollment for Alzheimer's clinical trials ...